Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$222,484
-$12,633 QoQ
Shares Held
1,761
+4.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,862
of 2,266 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beaumont Financial Advisors, LLC holds $40,048,849 across 7 Drug Manufacturers - General names. GILD ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
111,216 | $28,245,527 | |
| 2 | LLY |
ELI LILLY & Co
|
4,760 | $5,709,287 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,195 | $1,952,557 | |
| 4 | ABBV |
AbbVie Inc.
|
7,660 | $1,927,562 | |
| 5 | AMGN |
Amgen Inc
|
4,130 | $1,495,555 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,606 | $495,877 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
1,761 | $222,484 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,484 | 1,761 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $235,117 | 1,687 | Shares | Sole | 2026-05-05 | |
| 2025-09-30 | $236,430 | 2,130 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $232,272 | 2,095 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $233,624 | 2,085 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||